Mettler-Toledo International Inc.
Mettler-Toledo International Inc. 0K10.L Peers
See (0K10.L) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 0K10.L | £1,206.32 | +1.36% | 25.1B | 35.43 | £34.05 | N/A |
| 0R0H.L | £426.55 | +3.95% | 154.4B | 22.23 | £19.19 | +0.38% |
| 0QZU.L | £468.65 | +1.92% | 119.9B | 49.27 | £9.48 | N/A |
| 0M3Q.L | £149.51 | +1.25% | 66.6B | 34.31 | £4.36 | +1.28% |
| 0R2M.L | £557.76 | +2.03% | 59.2B | 7.93 | £70.31 | +0.32% |
| 0HD2.L | £322.40 | +0.01% | 42B | -43.04 | -£7.49 | N/A |
| 0RD1.L | £697.00 | -1.53% | 41.2B | -548.82 | -£1.27 | N/A |
| 0HAV.L | £115.27 | +2.05% | 32.7B | 27.81 | £4.15 | +0.85% |
| 0JDM.L | £188.85 | +18.29% | 27.6B | 34.11 | £5.54 | N/A |
| 0RQO.L | £312.80 | -3.93% | 20.6B | -245.53 | -£1.27 | N/A |
Stock Comparison
0K10.L vs 0R0H.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0R0H.L has a market cap of 154.4B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0R0H.L trades at £426.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0R0H.L's P/E ratio is 22.23. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0R0H.L's ROE of +0.13%. Regarding short-term risk, 0K10.L is less volatile compared to 0R0H.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QZU.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0QZU.L has a market cap of 119.9B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0QZU.L trades at £468.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0QZU.L's P/E ratio is 49.27. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QZU.L's ROE of -0.06%. Regarding short-term risk, 0K10.L is less volatile compared to 0QZU.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0M3Q.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0M3Q.L has a market cap of 66.6B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0M3Q.L trades at £149.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0M3Q.L's P/E ratio is 34.31. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0M3Q.L's ROE of +0.51%. Regarding short-term risk, 0K10.L is less volatile compared to 0M3Q.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0R2M.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0R2M.L has a market cap of 59.2B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0R2M.L trades at £557.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0R2M.L's P/E ratio is 7.93. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0R2M.L's ROE of +0.15%. Regarding short-term risk, 0K10.L is less volatile compared to 0R2M.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HD2.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0HD2.L has a market cap of 42B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0HD2.L trades at £322.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0HD2.L's P/E ratio is -43.04. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HD2.L's ROE of +9.05%. Regarding short-term risk, 0K10.L is less volatile compared to 0HD2.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0RD1.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0RD1.L has a market cap of 41.2B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0RD1.L trades at £697.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0RD1.L's P/E ratio is -548.82. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0RD1.L's ROE of +0.17%. Regarding short-term risk, 0K10.L is less volatile compared to 0RD1.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HAV.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0HAV.L has a market cap of 32.7B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0HAV.L trades at £115.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0HAV.L's P/E ratio is 27.81. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HAV.L's ROE of +0.21%. Regarding short-term risk, 0K10.L is less volatile compared to 0HAV.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JDM.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0JDM.L has a market cap of 27.6B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0JDM.L trades at £188.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0JDM.L's P/E ratio is 34.11. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JDM.L's ROE of +0.20%. Regarding short-term risk, 0K10.L is less volatile compared to 0JDM.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0RQO.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0RQO.L has a market cap of 20.6B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0RQO.L trades at £312.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0RQO.L's P/E ratio is -245.53. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0RQO.L's ROE of +0.18%. Regarding short-term risk, 0K10.L is less volatile compared to 0RQO.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0REZ.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0REZ.L has a market cap of 20.2B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0REZ.L trades at £172.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0REZ.L's P/E ratio is 29.31. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0REZ.L's ROE of +0.06%. Regarding short-term risk, 0K10.L is less volatile compared to 0REZ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0SAN.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0SAN.L has a market cap of 19.8B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0SAN.L trades at £45.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0SAN.L's P/E ratio is N/A. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0SAN.L's ROE of +0.00%. Regarding short-term risk, 0K10.L is less volatile compared to 0SAN.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JAV.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0JAV.L has a market cap of 19.4B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0JAV.L trades at £102.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0JAV.L's P/E ratio is -27.06. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JAV.L's ROE of -4.47%. Regarding short-term risk, 0K10.L is less volatile compared to 0JAV.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0R1B.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0R1B.L has a market cap of 18.6B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0R1B.L trades at £126.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0R1B.L's P/E ratio is N/A. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0R1B.L's ROE of +0.09%. Regarding short-term risk, 0K10.L is less volatile compared to 0R1B.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0LTI.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0LTI.L has a market cap of 17.1B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0LTI.L trades at £287.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0LTI.L's P/E ratio is 25.13. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0LTI.L's ROE of +0.39%. Regarding short-term risk, 0K10.L is less volatile compared to 0LTI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0J8Z.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0J8Z.L has a market cap of 15.7B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0J8Z.L trades at £98.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0J8Z.L's P/E ratio is 21.73. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0J8Z.L's ROE of -0.46%. Regarding short-term risk, 0K10.L is less volatile compared to 0J8Z.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0J9P.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0J9P.L has a market cap of 13.2B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0J9P.L trades at £68.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0J9P.L's P/E ratio is 16.25. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0J9P.L's ROE of +0.01%. Regarding short-term risk, 0K10.L is less volatile compared to 0J9P.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0K6R.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0K6R.L has a market cap of 13.1B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0K6R.L trades at £132.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0K6R.L's P/E ratio is 181.55. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0K6R.L's ROE of +0.12%. Regarding short-term risk, 0K10.L is less volatile compared to 0K6R.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IJO.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0IJO.L has a market cap of 12.1B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0IJO.L trades at £44.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0IJO.L's P/E ratio is 47.84. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IJO.L's ROE of +0.29%. Regarding short-term risk, 0K10.L is less volatile compared to 0IJO.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HNC.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0HNC.L has a market cap of 11.3B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0HNC.L trades at £58.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0HNC.L's P/E ratio is 273.58. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HNC.L's ROE of +0.09%. Regarding short-term risk, 0K10.L is less volatile compared to 0HNC.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0LSZ.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0LSZ.L has a market cap of 10B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0LSZ.L trades at £11.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0LSZ.L's P/E ratio is 1.59. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0LSZ.L's ROE of -0.70%. Regarding short-term risk, 0K10.L is more volatile compared to 0LSZ.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HOJ.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0HOJ.L has a market cap of 8.4B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0HOJ.L trades at £129.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0HOJ.L's P/E ratio is -11.70. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HOJ.L's ROE of -0.49%. Regarding short-term risk, 0K10.L is more volatile compared to 0HOJ.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0I3Q.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0I3Q.L has a market cap of 7.4B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0I3Q.L trades at £70.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0I3Q.L's P/E ratio is 76.61. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0I3Q.L's ROE of +0.20%. Regarding short-term risk, 0K10.L is less volatile compared to 0I3Q.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0J2O.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0J2O.L has a market cap of 7.1B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0J2O.L trades at £57.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0J2O.L's P/E ratio is 19.15. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0J2O.L's ROE of +1.22%. Regarding short-term risk, 0K10.L is less volatile compared to 0J2O.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JDI.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0JDI.L has a market cap of 6.7B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0JDI.L trades at £41.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0JDI.L's P/E ratio is -1498.14. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JDI.L's ROE of -0.92%. Regarding short-term risk, 0K10.L is less volatile compared to 0JDI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HKF.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0HKF.L has a market cap of 5.2B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0HKF.L trades at £106.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0HKF.L's P/E ratio is -28.65. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HKF.L's ROE of -3.64%. Regarding short-term risk, 0K10.L is less volatile compared to 0HKF.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0VGI.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0VGI.L has a market cap of 5.1B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0VGI.L trades at £31.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0VGI.L's P/E ratio is -13.01. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0VGI.L's ROE of +0.19%. Regarding short-term risk, 0K10.L is less volatile compared to 0VGI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QND.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0QND.L has a market cap of 4.2B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0QND.L trades at £55.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0QND.L's P/E ratio is 34.42. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QND.L's ROE of +0.09%. Regarding short-term risk, 0K10.L is less volatile compared to 0QND.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QQO.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0QQO.L has a market cap of 4B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0QQO.L trades at £87.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0QQO.L's P/E ratio is 3.99. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QQO.L's ROE of +0.17%. Regarding short-term risk, 0K10.L is less volatile compared to 0QQO.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0Y5E.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0Y5E.L has a market cap of 3.8B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0Y5E.L trades at £27.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0Y5E.L's P/E ratio is -33.50. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0Y5E.L's ROE of -0.04%. Regarding short-term risk, 0K10.L is less volatile compared to 0Y5E.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0VQA.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0VQA.L has a market cap of 3.6B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0VQA.L trades at £31.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0VQA.L's P/E ratio is -43.58. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0VQA.L's ROE of -0.14%. Regarding short-term risk, 0K10.L is less volatile compared to 0VQA.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0ILL.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0ILL.L has a market cap of 2.7B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0ILL.L trades at £52.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0ILL.L's P/E ratio is 15.92. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0ILL.L's ROE of +0.26%. Regarding short-term risk, 0K10.L is less volatile compared to 0ILL.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0GZB.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0GZB.L has a market cap of 2.3B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0GZB.L trades at £203.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0GZB.L's P/E ratio is 31.04. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0GZB.L's ROE of +0.01%. Regarding short-term risk, 0K10.L is more volatile compared to 0GZB.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HB0.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0HB0.L has a market cap of 2.3B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0HB0.L trades at £39.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0HB0.L's P/E ratio is -6.14. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HB0.L's ROE of +0.59%. Regarding short-term risk, 0K10.L is less volatile compared to 0HB0.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0I5P.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0I5P.L has a market cap of 2.2B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0I5P.L trades at £32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0I5P.L's P/E ratio is -24.55. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0I5P.L's ROE of -0.64%. Regarding short-term risk, 0K10.L is more volatile compared to 0I5P.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QLN.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0QLN.L has a market cap of 2B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0QLN.L trades at £156.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0QLN.L's P/E ratio is 15.87. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QLN.L's ROE of +0.05%. Regarding short-term risk, 0K10.L is less volatile compared to 0QLN.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HF9.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0HF9.L has a market cap of 1.9B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0HF9.L trades at £6.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0HF9.L's P/E ratio is -6.24. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HF9.L's ROE of -0.17%. Regarding short-term risk, 0K10.L is less volatile compared to 0HF9.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0LB2.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0LB2.L has a market cap of 1.9B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0LB2.L trades at £34.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0LB2.L's P/E ratio is 26.13. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0LB2.L's ROE of +0.06%. Regarding short-term risk, 0K10.L is more volatile compared to 0LB2.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IMT.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0IMT.L has a market cap of 1.6B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0IMT.L trades at £60.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0IMT.L's P/E ratio is -23.72. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IMT.L's ROE of +0.00%. Regarding short-term risk, 0K10.L is less volatile compared to 0IMT.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0L35.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0L35.L has a market cap of 1.5B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0L35.L trades at £14.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0L35.L's P/E ratio is -3.38. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0L35.L's ROE of -0.20%. Regarding short-term risk, 0K10.L is less volatile compared to 0L35.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JBU.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0JBU.L has a market cap of 1.4B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0JBU.L trades at £13.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0JBU.L's P/E ratio is -2.62. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JBU.L's ROE of -0.59%. Regarding short-term risk, 0K10.L is less volatile compared to 0JBU.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IDA.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0IDA.L has a market cap of 1.3B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0IDA.L trades at £11.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0IDA.L's P/E ratio is 14.89. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IDA.L's ROE of -0.10%. Regarding short-term risk, 0K10.L is less volatile compared to 0IDA.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0KCS.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0KCS.L has a market cap of 1.1B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0KCS.L trades at £1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0KCS.L's P/E ratio is -7.65. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0KCS.L's ROE of -0.03%. Regarding short-term risk, 0K10.L is less volatile compared to 0KCS.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0RGI.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0RGI.L has a market cap of 1B. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0RGI.L trades at £63.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0RGI.L's P/E ratio is 48.35. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0RGI.L's ROE of +0.14%. Regarding short-term risk, 0K10.L is less volatile compared to 0RGI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JDK.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0JDK.L has a market cap of 976.1M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0JDK.L trades at £3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0JDK.L's P/E ratio is -1.32. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JDK.L's ROE of -0.51%. Regarding short-term risk, 0K10.L is less volatile compared to 0JDK.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HFR.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0HFR.L has a market cap of 947.8M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0HFR.L trades at £11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0HFR.L's P/E ratio is -19.18. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HFR.L's ROE of -0.31%. Regarding short-term risk, 0K10.L is less volatile compared to 0HFR.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0O1O.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0O1O.L has a market cap of 913.3M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0O1O.L trades at £77.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0O1O.L's P/E ratio is 14.56. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0O1O.L's ROE of +0.10%. Regarding short-term risk, 0K10.L is more volatile compared to 0O1O.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IV3.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0IV3.L has a market cap of 802.5M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0IV3.L trades at £1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0IV3.L's P/E ratio is -3.51. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IV3.L's ROE of -0.48%. Regarding short-term risk, 0K10.L is less volatile compared to 0IV3.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0EE0.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0EE0.L has a market cap of 777.9M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0EE0.L trades at £14.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0EE0.L's P/E ratio is 2.06. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0EE0.L's ROE of -4.84%. Regarding short-term risk, 0K10.L is less volatile compared to 0EE0.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QNA.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0QNA.L has a market cap of 661.5M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0QNA.L trades at £53.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0QNA.L's P/E ratio is -92.14. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QNA.L's ROE of +1.59%. Regarding short-term risk, 0K10.L is less volatile compared to 0QNA.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0K16.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0K16.L has a market cap of 597.7M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0K16.L trades at £14.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0K16.L's P/E ratio is -11.22. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0K16.L's ROE of -9.32%. Regarding short-term risk, 0K10.L is less volatile compared to 0K16.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0RA9.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0RA9.L has a market cap of 577.6M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0RA9.L trades at £9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0RA9.L's P/E ratio is -3.68. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0RA9.L's ROE of -2.11%. Regarding short-term risk, 0K10.L is less volatile compared to 0RA9.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0W4N.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0W4N.L has a market cap of 515.9M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0W4N.L trades at £28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0W4N.L's P/E ratio is -23.11. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0W4N.L's ROE of -0.24%. Regarding short-term risk, 0K10.L is less volatile compared to 0W4N.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0OB3.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0OB3.L has a market cap of 444.5M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0OB3.L trades at £2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0OB3.L's P/E ratio is -3.70. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0OB3.L's ROE of -0.43%. Regarding short-term risk, 0K10.L is less volatile compared to 0OB3.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0UNL.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0UNL.L has a market cap of 429.6M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0UNL.L trades at £24.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0UNL.L's P/E ratio is -9.32. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0UNL.L's ROE of -2.62%. Regarding short-term risk, 0K10.L is less volatile compared to 0UNL.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0K3W.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0K3W.L has a market cap of 416.8M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0K3W.L trades at £4.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0K3W.L's P/E ratio is -41.48. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0K3W.L's ROE of -0.14%. Regarding short-term risk, 0K10.L is more volatile compared to 0K3W.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0RNK.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0RNK.L has a market cap of 387.4M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0RNK.L trades at £2.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0RNK.L's P/E ratio is -2.20. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0RNK.L's ROE of +1.98%. Regarding short-term risk, 0K10.L is more volatile compared to 0RNK.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0DTF.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0DTF.L has a market cap of 382M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0DTF.L trades at £22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0DTF.L's P/E ratio is 13.50. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0DTF.L's ROE of +0.03%. Regarding short-term risk, 0K10.L is more volatile compared to 0DTF.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IGA.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0IGA.L has a market cap of 380.5M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0IGA.L trades at £7.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0IGA.L's P/E ratio is 2.36. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IGA.L's ROE of -0.27%. Regarding short-term risk, 0K10.L is less volatile compared to 0IGA.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0H7R.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0H7R.L has a market cap of 339.3M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0H7R.L trades at £6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0H7R.L's P/E ratio is -8.21. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0H7R.L's ROE of -1.65%. Regarding short-term risk, 0K10.L is less volatile compared to 0H7R.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0J4V.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0J4V.L has a market cap of 294.4M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0J4V.L trades at £1.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0J4V.L's P/E ratio is -0.84. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0J4V.L's ROE of +0.37%. Regarding short-term risk, 0K10.L is more volatile compared to 0J4V.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0LOV.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0LOV.L has a market cap of 284.2M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0LOV.L trades at £5.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0LOV.L's P/E ratio is -12.58. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0LOV.L's ROE of +58.06%. Regarding short-term risk, 0K10.L is less volatile compared to 0LOV.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IIM.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0IIM.L has a market cap of 238.8M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0IIM.L trades at £1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0IIM.L's P/E ratio is -0.19. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IIM.L's ROE of +0.40%. Regarding short-term risk, 0K10.L is less volatile compared to 0IIM.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IFK.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0IFK.L has a market cap of 224.6M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0IFK.L trades at £3.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0IFK.L's P/E ratio is -1.14. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IFK.L's ROE of -1.66%. Regarding short-term risk, 0K10.L is less volatile compared to 0IFK.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0GP7.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0GP7.L has a market cap of 224.1M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0GP7.L trades at £2.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0GP7.L's P/E ratio is -1.31. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0GP7.L's ROE of -0.38%. Regarding short-term risk, 0K10.L is more volatile compared to 0GP7.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0RDB.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0RDB.L has a market cap of 219M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0RDB.L trades at £2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0RDB.L's P/E ratio is -32.10. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0RDB.L's ROE of -0.03%. Regarding short-term risk, 0K10.L is more volatile compared to 0RDB.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QAV.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0QAV.L has a market cap of 206.9M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0QAV.L trades at £4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0QAV.L's P/E ratio is -3.14. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QAV.L's ROE of +2.83%. Regarding short-term risk, 0K10.L is less volatile compared to 0QAV.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0NZY.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0NZY.L has a market cap of 201.2M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0NZY.L trades at £39.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0NZY.L's P/E ratio is 30.50. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0NZY.L's ROE of +0.14%. Regarding short-term risk, 0K10.L is more volatile compared to 0NZY.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QN1.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0QN1.L has a market cap of 187M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0QN1.L trades at £14.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0QN1.L's P/E ratio is -8.90. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QN1.L's ROE of -1.11%. Regarding short-term risk, 0K10.L is less volatile compared to 0QN1.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0H8T.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0H8T.L has a market cap of 178.1M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0H8T.L trades at £1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0H8T.L's P/E ratio is -1.21. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0H8T.L's ROE of -0.94%. Regarding short-term risk, 0K10.L is less volatile compared to 0H8T.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QOI.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0QOI.L has a market cap of 133.7M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0QOI.L trades at £7.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0QOI.L's P/E ratio is -8.29. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QOI.L's ROE of +1.28%. Regarding short-term risk, 0K10.L is less volatile compared to 0QOI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0R1D.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0R1D.L has a market cap of 124.4M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0R1D.L trades at £0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0R1D.L's P/E ratio is -0.40. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0R1D.L's ROE of -3.51%. Regarding short-term risk, 0K10.L is less volatile compared to 0R1D.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0N4A.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0N4A.L has a market cap of 124M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0N4A.L trades at £0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0N4A.L's P/E ratio is -0.89. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0N4A.L's ROE of -0.23%. Regarding short-term risk, 0K10.L is less volatile compared to 0N4A.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QXX.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0QXX.L has a market cap of 120.9M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0QXX.L trades at £3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0QXX.L's P/E ratio is 0.91. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QXX.L's ROE of -0.42%. Regarding short-term risk, 0K10.L is less volatile compared to 0QXX.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0OCQ.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0OCQ.L has a market cap of 101.7M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0OCQ.L trades at £0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0OCQ.L's P/E ratio is -3.73. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0OCQ.L's ROE of -4.66%. Regarding short-term risk, 0K10.L is less volatile compared to 0OCQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0SZI.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0SZI.L has a market cap of 99.6M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0SZI.L trades at £8.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0SZI.L's P/E ratio is -27.56. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0SZI.L's ROE of -0.37%. Regarding short-term risk, 0K10.L is less volatile compared to 0SZI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0O8G.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0O8G.L has a market cap of 92.1M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0O8G.L trades at £3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0O8G.L's P/E ratio is -14.05. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0O8G.L's ROE of -6.17%. Regarding short-term risk, 0K10.L is more volatile compared to 0O8G.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HIY.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0HIY.L has a market cap of 84.4M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0HIY.L trades at £12.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0HIY.L's P/E ratio is -3.41. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HIY.L's ROE of +0.18%. Regarding short-term risk, 0K10.L is less volatile compared to 0HIY.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0KCC.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0KCC.L has a market cap of 81.8M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0KCC.L trades at £2.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0KCC.L's P/E ratio is -3.45. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0KCC.L's ROE of -7.67%. Regarding short-term risk, 0K10.L is more volatile compared to 0KCC.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0Q77.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0Q77.L has a market cap of 74.7M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0Q77.L trades at £1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0Q77.L's P/E ratio is -4.00. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0Q77.L's ROE of +0.32%. Regarding short-term risk, 0K10.L is less volatile compared to 0Q77.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HX7.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0HX7.L has a market cap of 61.7M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0HX7.L trades at £0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0HX7.L's P/E ratio is -0.71. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HX7.L's ROE of -0.53%. Regarding short-term risk, 0K10.L is less volatile compared to 0HX7.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JGL.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0JGL.L has a market cap of 59.5M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0JGL.L trades at £1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0JGL.L's P/E ratio is -0.68. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JGL.L's ROE of -0.59%. Regarding short-term risk, 0K10.L is more volatile compared to 0JGL.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JW9.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0JW9.L has a market cap of 52.3M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0JW9.L trades at £6.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0JW9.L's P/E ratio is -13.27. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JW9.L's ROE of -1.27%. Regarding short-term risk, 0K10.L is less volatile compared to 0JW9.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0DOL.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0DOL.L has a market cap of 52.2M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0DOL.L trades at £1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0DOL.L's P/E ratio is 4.37. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0DOL.L's ROE of +0.03%. Regarding short-term risk, 0K10.L is more volatile compared to 0DOL.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0M40.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0M40.L has a market cap of 49M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0M40.L trades at £1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0M40.L's P/E ratio is -1.36. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0M40.L's ROE of -0.59%. Regarding short-term risk, Volatility data is not available for a full comparison. 0K10.L has daily volatility of 0.71 and 0M40.L has daily volatility of N/A.
0K10.L vs 0HOH.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0HOH.L has a market cap of 48.7M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0HOH.L trades at £8.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0HOH.L's P/E ratio is -0.77. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HOH.L's ROE of +18.95%. Regarding short-term risk, 0K10.L is less volatile compared to 0HOH.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0RU5.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0RU5.L has a market cap of 48.2M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0RU5.L trades at £1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0RU5.L's P/E ratio is -0.35. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0RU5.L's ROE of -1.02%. Regarding short-term risk, 0K10.L is less volatile compared to 0RU5.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JQ2.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0JQ2.L has a market cap of 38M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0JQ2.L trades at £5.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0JQ2.L's P/E ratio is N/A. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JQ2.L's ROE of -3.69%. Regarding short-term risk, 0K10.L is more volatile compared to 0JQ2.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0R3M.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0R3M.L has a market cap of 37.6M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0R3M.L trades at £1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0R3M.L's P/E ratio is -2.28. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0R3M.L's ROE of -1.88%. Regarding short-term risk, 0K10.L is less volatile compared to 0R3M.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IL8.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0IL8.L has a market cap of 29.5M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0IL8.L trades at £7.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0IL8.L's P/E ratio is -2.48. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IL8.L's ROE of +0.05%. Regarding short-term risk, 0K10.L is less volatile compared to 0IL8.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QKQ.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0QKQ.L has a market cap of 28.9M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0QKQ.L trades at £2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0QKQ.L's P/E ratio is -229.50. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QKQ.L's ROE of -0.40%. Regarding short-term risk, 0K10.L is less volatile compared to 0QKQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0T6G.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0T6G.L has a market cap of 26.7M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0T6G.L trades at £2.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0T6G.L's P/E ratio is -45.64. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0T6G.L's ROE of -1.80%. Regarding short-term risk, 0K10.L is less volatile compared to 0T6G.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QFK.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0QFK.L has a market cap of 21.5M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0QFK.L trades at £0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0QFK.L's P/E ratio is -0.55. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QFK.L's ROE of +0.91%. Regarding short-term risk, 0K10.L is more volatile compared to 0QFK.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0KF3.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0KF3.L has a market cap of 8.2M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0KF3.L trades at £0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0KF3.L's P/E ratio is -1.13. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0KF3.L's ROE of +4.54%. Regarding short-term risk, 0K10.L is less volatile compared to 0KF3.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs CBX.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, CBX.L has a market cap of 2.2M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while CBX.L trades at £0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas CBX.L's P/E ratio is -0.37. In terms of profitability, 0K10.L's ROE is -5.82%, compared to CBX.L's ROE of -0.93%. Regarding short-term risk, 0K10.L is less volatile compared to CBX.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0YC0.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0YC0.L has a market cap of 1.8M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0YC0.L trades at £0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0YC0.L's P/E ratio is -0.10. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0YC0.L's ROE of -2.74%. Regarding short-term risk, 0K10.L is less volatile compared to 0YC0.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs KNB.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, KNB.L has a market cap of 1.4M. Regarding current trading prices, 0K10.L is priced at £1,206.32, while KNB.L trades at £0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas KNB.L's P/E ratio is -0.23. In terms of profitability, 0K10.L's ROE is -5.82%, compared to KNB.L's ROE of -1.22%. Regarding short-term risk, 0K10.L is more volatile compared to KNB.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0L85.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0L85.L has a market cap of 551.3K. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0L85.L trades at £0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0L85.L's P/E ratio is N/A. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0L85.L's ROE of -19.05%. Regarding short-term risk, 0K10.L is more volatile compared to 0L85.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HL9.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0HL9.L has a market cap of 274.1K. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0HL9.L trades at £0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0HL9.L's P/E ratio is -0.03. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HL9.L's ROE of -1.94%. Regarding short-term risk, 0K10.L is more volatile compared to 0HL9.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0G99.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 25.1B. In comparison, 0G99.L has a market cap of 263.4K. Regarding current trading prices, 0K10.L is priced at £1,206.32, while 0G99.L trades at £0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 35.43, whereas 0G99.L's P/E ratio is -0.36. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0G99.L's ROE of -0.01%. Regarding short-term risk, 0K10.L is more volatile compared to 0G99.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.